SCHEMBL4715459

SCHEMBL4715459

C[Si](C)(C)CCOCc1cccc2[nH]c(C=O)nc12

nearest known ligand 0.33

Predicted protein targets (top 5)

geneUniProtsupporting neighboursconfidence
▸ ADAMTS5 Q9UNA0 2/20 0.33
▸ ATP4A P20648 1/20 0.31
▸ ATP4B P51164 1/20 0.31
▸ RET P07949 1/20 0.31
▸ HCAR2 Q8TDS4 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4711825 0.79 CHEK1 (0.35) RETHCAR2
SCHEMBL9675516 0.73 DUT (0.34) ADAMTS5
SCHEMBL30180820 0.72 ADAMTS5 (0.55) ADAMTS5
SCHEMBL1768203 0.72 ADAMTS5 (0.55) ADAMTS5
SCHEMBL23782284 0.70 GNRHR (0.36) ADAMTS5
SCHEMBL23782187 0.68 ALDH1A1 (0.50) —
SCHEMBL3945997 0.66 — —
SCHEMBL23782273 0.66 CYP2A6 (0.41) ADAMTS5
SCHEMBL2767156 0.66 EGLN1 (0.42) ADAMTS5
SCHEMBL5382360 0.66 TDP1 (0.50) ADAMTS5ATP4AATP4B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1465889-A4 CHEMOKINE RECEPTOR BINDING HETEROCYCLIC COMPOUNDS WITH ENHANCED EFFICACY ANORMED INC (CA) 2008-05-14 — — EP disclosed
EP-1628533-A2 CHEMOKINE RECEPTOR BINDING HETEROCYCLIC COMPOUNDS WITH ENHANCED EFFICACY ANORMED INC. (CA) 2006-03-01 — — EP disclosed
WO-2004106493-A2 CHEMOKINE RECEPTOR BINDING HETEROCYCLIC COMPOUNDS WITH ENHANCED EFFICACY ANORMED INC. (CA) 2004-12-09 — — WO disclosed
EP-1465889-A1 CHEMOKINE RECEPTOR BINDING HETEROCYCLIC COMPOUNDS WITH ENHANCED EFFICACY AnorMED Inc. (CA) 2004-10-13 — — EP disclosed
WO-2003055876-A1 CHEMOKINE RECEPTOR BINDING HETEROCYCLIC COMPOUNDS WITH ENHANCED EFFICACY ANORMED INC. (CA) 2003-07-10 — — WO disclosed
EP-1317445-A2 CHEMOKINE RECEPTOR BINDING HETEROCYCLIC COMPOUNDS ANORMED INC. (CA) 2003-06-11 — — EP disclosed
WO-2002022600-A2 CHEMOKINE RECEPTOR BINDING HETEROCYCLIC COMPOUNDS ANORMED INC. (CA) 2002-03-21 — — WO disclosed
Send feedback